Evidence map›Paper›PMID 27694967›Full record

ArticleScientific reports2016

Regionalization of Habitat Suitability of Masson's Pine based on geographic information system and Fuzzy Matter-Element Model.

Xiuteng Zhou, Manxi Zhao, Liangyun Zhou, Guang Yang, Luqi Huang, Cuiqi Yan, Quanshu Huang, Liang Ye, Xiaobo Zhang, Lanpin Guo and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Xiuteng ZhouState Key Laboratory of Dao-di Herbs, National Resource Center for Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, People's Republic of China.
Manxi ZhaoThe Laboratory of Innovative Drug Development and Translational Medicine Research of Traditional Chinese Medicine, Chengdu Kanghong Pharmaceutical Limited Company, Chengdu 610036, People's Republic of China.
Liangyun ZhouState Key Laboratory of Dao-di Herbs, National Resource Center for Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, People's Republic of China.
Guang YangState Key Laboratory of Dao-di Herbs, National Resource Center for Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, People's Republic of China.
Luqi HuangState Key Laboratory of Dao-di Herbs, National Resource Center for Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, People's Republic of China.
Cuiqi YanThe Laboratory of Innovative Drug Development and Translational Medicine Research of Traditional Chinese Medicine, Chengdu Kanghong Pharmaceutical Limited Company, Chengdu 610036, People's Republic of China.
Quanshu HuangThe Laboratory of Innovative Drug Development and Translational Medicine Research of Traditional Chinese Medicine, Chengdu Kanghong Pharmaceutical Limited Company, Chengdu 610036, People's Republic of China.
Liang YeThe Laboratory of Innovative Drug Development and Translational Medicine Research of Traditional Chinese Medicine, Chengdu Kanghong Pharmaceutical Limited Company, Chengdu 610036, People's Republic of China.
Xiaobo ZhangState Key Laboratory of Dao-di Herbs, National Resource Center for Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, People's Republic of China.
Lanpin GuoState Key Laboratory of Dao-di Herbs, National Resource Center for Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, People's Republic of China.
Xiao KeThe Laboratory of Innovative Drug Development and Translational Medicine Research of Traditional Chinese Medicine, Chengdu Kanghong Pharmaceutical Limited Company, Chengdu 610036, People's Republic of China.
Jiao GuoGuangdong TCM Key Laboratory for Metabolic Diseases, Guangzhou 510006, People's Republic of China.
Chinese Academy of Medical Sciences & Peking Union Medical College · CNGuangdong Pharmaceutical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pine needles have been widely used in the development of anti-hypertensive and anti-hyperlipidemic agents and health food. However, the widespread distribution of this tree poses great obstacles to the quality control and efficacy evaluation. To facilitate the effective and rational exploitation of Masson's pine (Pinus massoniana Lamb), as well as ensure effective development of Masson's pine needles as a medicinal agent, we investigated the spatial distribution of habitat suitability and evaluated the optimal ranges of ecological factors of P. massoniana with 280 samples collected from 12 provinces in China through the evaluation of four constituents known to be effective medicinally. The results of habitat suitability evaluation were also verified by Root Mean Square Error (RMSE). Finally, five ecological factors were chosen in the establishment of a habitat suitability evaluation system. The most suitable areas for P. massoniana growth were mainly concentrated in the middle and lower reaches of the Yangtze River basin, such as Sichuan, Guizhou, and Jiangxi provinces, while the best quality needles were from Guizhou, Sichuan, and the junction area of Chongqing, Hunan, and Hubei provinces. This information revealed that suitable areas for effective constituent accumulation of Masson's pine needles accounted for only 7.41% of its distribution area.

Indexed as

EcosystemGeographic Information SystemsModels, TheoreticalChinaEcologyFuzzy LogicGeographyPinus

Identifiers

PMID27694967
PMCPMC5046140
OpenAlexW2529200924

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.